American Heart Journal
Volume 151, Issue 4 , Pages 916-922 , April 2006

Frequency of clinically unsuspected myocardial injury at a children's hospital

  • Steven E. Lipshultz, MD

      Affiliations

    • Department of Cardiology, Harvard Medical School, Boston, MA
    • Department of Pediatrics, Harvard Medical School, Boston, MA
    • Division of Pediatric Cardiology, Golisano Children's Hospital at Strong and University of Rochester Medical Center, Rochester, NY
    • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY
    • Department of Pediatrics, University of Miami Miller School of Medicine, Holtz Children's Hospital of the University of Miami-Jackson Memorial Medical Center, Batchelor Children's Research Institute, and the Sylvester Comprehensive Cancer Center, Miami, FL
    • Corresponding Author InformationReprint requests: Steven E. Lipshultz, MD, Department of Pediatrics (D820), University of Miami Miller School of Medicine, P.O. Box 016820, Miami, FL 33101.
    • ,
  • Julia C.L. Wong, MD

      Affiliations

    • Department of Cardiology, Harvard Medical School, Boston, MA
    • Harvard School of Public Health, Harvard Medical School, Boston, MA
    • ,
  • Stuart R. Lipsitz, DSc

      Affiliations

    • Department of Biometry and Epidemiology, Medical University of South Carolina, Charleston, SC
    • ,
  • Valeriano C. Simbre II, MD

      Affiliations

    • Division of Pediatric Cardiology, Golisano Children's Hospital at Strong and University of Rochester Medical Center, Rochester, NY
    • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY
    • ,
  • Karolina M. Zareba

      Affiliations

    • Division of Pediatric Cardiology, Golisano Children's Hospital at Strong and University of Rochester Medical Center, Rochester, NY
    • ,
  • Vartouhi Galpechian

      Affiliations

    • Division of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA
    • ,
  • Nader Rifai, PhD

      Affiliations

    • Division of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA
    • Department of Pathology, Harvard Medical School, Boston, MA

Received 2 May 2005 ,Accepted 20 June 2005.

References 

  1. Lipshultz SE. Ventricular dysfunction clinical research in infants, children and adolescents. Prog Pediatr Cardiol. 2000;12:1–28
  2. Ottlinger M, Pearsall L, Rifai N, et al. New developments in the biochemical assessment of myocardial injury in children: Troponin T and I as highly sensitive and specific markers of myocardial injury. Prog Pediatr Cardiol. 1998;8:71–81
  3. Rohlicek CV. Diagnostic use of cardiac troponins in pediatric patients. Monitor. 2001;19:2–6[A newsletter from the pediatric and maternal-fetal division of AACC]
  4. Kanaan UB, Chiang VW. Cardiac troponins in pediatrics. Pediatr Emerg Care. 2004;20:323–329
  5. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388–1398
  6. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076–1082
  7. Moran AM, Lipshultz S, Rifai N, et al. Non-invasive assessment of rejection in pediatric heart transplant patients: serologic and echocardiographic prediction of biopsy proven myocardial rejection. J Heart Lung Transplant. 2000;19:756–764
  8. Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997;95:163–168
  9. Lauer B, Niederau C, Kuhl U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30:1354–1359
  10. Fenton KD, Sable CA, Bell MJ, et al. Increases in serum levels of troponin I are associated with cardiac dysfunction and disease severity in pediatric patients with septic shock. Pediatr Crit Care Med. 2004;5:533–538
  11. Checchia PA, Sehra R, Moynihan J, et al. Myocardial injury in children following resuscitation after cardiac arrest. Resuscitation. 2003;57:131–137
  12. Lipshultz SE, Rifai N, Sallan SE, et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation. 1997;96:2641–2648
  13. Hirsch R, Dent CL, Wood MK, et al. Patterns and potential value of elevation of cardiac troponin I elevations after pediatric cardiac operations. Ann Thorac Surg. 1998;65:1394–1399
  14. Hirsch R, Landt Y, Porter S, et al. Cardiac troponin I in pediatrics: normal values and potential use in the assessment of cardiac injury. J Pediatr. 1997;130:872–877
  15. Taggart DP, Hadjinikolas L, Hooper J, et al. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations. J Thorac Cardiovasc Surg. 1997;113:728–735
  16. Immer FF, Stocker F, Seiler AM, et al. Troponin-I for prediction of early postoperative course after pediatric cardiac surgery. J Am Coll Cardiol. 1999;33:1719–1723
  17. Immer FF, Stocker F, Seiler AM, et al. Troponin-T: improved diagnostic assessment of myocardial damage in childhood. Acta Paediatr. 1997;86:1321–1327
  18. Herman EH, Lipshultz SE, Rifai N, et al. Elevated serum levels and loss from cardiac myocytes in doxorubicin toxicity. Cancer Res. 1998;58:195–197
  19. Herman EH, Zhang J, Lipshultz SE, et al. Correlation between serum levels of cardiac troponin-T and the severity of chronic cardiomyopathy induced by doxorubicin. J Clin Oncol. 1999;17:2237–2243
  20. Herman EH, Zhang J, Rifai N, et al. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol. 2001;48:297–304
  21. Herman E, Lipshultz SE, Ferrans VJ. The use of cardiac biomarkers to detect myocardial damage induced by chemotherapeutic agents. In:  Wu AHB editors. Cardiac biomarkers. 2nd ed.. New York: Humana Press; 2002;
  22. Lipshultz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004;351:145–153
  23. Simbre VC, Adams MJ, Deshpande SS, et al. Cardiomyopathy caused by antineoplastic therapies. Curr Treat Options Cardiovasc Med. 2001;3:493–505
  24. Chiang VW, Burns JP, Rifai N, et al. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr. 2000;137:73–77
  25. Lipshultz SE, Somers MJ, Lipsitz SR, et al. Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. Pediatrics. 2003;112:79–86
  26. Briassoulis G, Papadopoulos G, Zavras N, et al. Cardiac troponin I in fulminant adenovirus myocarditis treated with a 24-hour infusion of high-dose intravenous immunoglobulin. Pediatr Cardiol. 2000;21:391–394
  27. Lemesle FG, Lumumba E, Spadaro Sapari J, et al. Troponin 1c in acute myocarditis in children. Presse Med. 2000;29:81–82
  28. Kim M, Kim K. Elevation of cardiac troponin I in the acute stage of Kawasaki disease. Pediatr Cardiol. 1999;20:184–188
  29. Lewes D, Rainford DJ, Lane WF. Symptomless myocarditis and myalgia in viral and Mycoplasma pneumoniae infections. Br Heart J. 1974;36:924–932
  30. Claydon SM. Myocarditis as an incidental finding in young men dying from unnatural causes. Med Sci Law. 1989;29:55–58
  31. Burch GE, Sun SC, Colcolough HL, et al. Coxsackie virus valvulitis and myocarditis observed at routine autopsy. Experientia. 1967;23:1041–1042
  32. Passarino G, Burlo P, Ciccone G, et al. Prevalence of myocarditis at autopsy in Turin, Italy. Arch Pathol Lab Med. 1997;121:619–622
  33. Noren GR, Staley NA, Bandt CM, et al. Occurrence of myocarditis in sudden death in children. J Forensic Sci. 1977;22:188–196
  34. Soongswang J, Durongpisitkul K, Ratanarapee S, et al. Cardiac troponin T: its role in the diagnosis of clinically suspected acute myocarditis and chronic dilated cardiomyopathy in children. Pediatr Cardiol. 2002;23:531–535
  35. Ellingsen CL, Hetland O. Serum concentrations of cardiac troponin T in sudden death. Am J Forensic Med Pathol. 2004;25:213–215
  36. Bowles NE, Kearney D, Ni J, et al. The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol. 1999;34:857–865
  37. Bowles NE, Richardson PJ, Olsen EG, et al. Detection of Coxsackie-B-virus-specific RNA sequences in myocardium biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1986;1:1120–1123
  38. Tracy S, Wiegand V, McManus B, et al. Molecular approaches to enteroviral diagnosis in idiopathic dilated cardiomyopathy and myocarditis. J Am Coll Cardiol. 1990;15:1688–1694
  39. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis: rapid diagnosis by PCR in children. Circulation. 1994;90:330–339
  40. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult (second of two parts). N Engl J Med. 1982;307:1119–1126
  41. Dec GW, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885–890
  42. Matsumori A, Kawai C. An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation. 1982;66:355–360
  43. Gagliardi MG, Bevilacqua M, Squitieri C, et al. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant. 1993;12:S224–S229
  44. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res. 1994;74:182–188
  45. Friedman RA. Myocarditis. In:  Garson A,  Bricker JT,  McNamara DG editor. The science and practice of pediatric cardiology. Philadelphia: Lea and Febiger; 1990;p. 1577–1589
  46. Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol. 2001;16:77–83
  47. Lipshultz SE, Orav EJ, Sanders SP, et al. Immunoglobulins and cardiac structure and function in HIV-infected children. Circulation. 1995;92:2220–2225
  48. Hayakawa M, Inoh T, Yokota Y, et al. A long-term follow-up study of acute viral and idiopathic myocarditis. Jpn Circ J. 1983;47:1304–1309
  49. Montague TJ, Marrie TJ, Bewick DJ, et al. Cardiac effects of common viral illnesses. Chest. 1988;94:919–925
  50. Morgera T, Di Lenarda A, Dreas L, et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J. 1992;124:455–467
  51. Zee-Cheng CS, Tsai CC, Palmer DC, et al. High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy. J Am Coll Cardiol. 1984;3:63–70
  52. Levine HD. Virus myocarditis: a critique of the literature from clinical, electrocardiographic and pathologic standpoints. Am J Med Sci. 1979;277:132–143
  53. Scott LP, Gutelius MF, Parrott RH. Children with acute respiratory tract infections: an electrocardiographic survey. Am J Dis Child. 1970;119:111–113
  54. Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem. 1995;28:1–29
  55. Keffer JH. Myocardial markers of injury: evolution and insights. Am J Clin Pathol. 1996;105:305–320
  56. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s?. Circulation. 1993;88:750–763
  57. Mangano DT. Beyond CK-MB. Biochemical markers for perioperative myocardial infarction. Anesthesiology. 1994;81:1317–1320
  58. Primhak RA, Jedeikin R, Ellis G, et al. Myocardial ischaemia in asphyxia neonatorum. Electrocardiographic, enzymatic and histological correlations. Acta Paediatr Scand. 1985;74:595–600
  59. Tsung SH. Several conditions causing elevation of serum CK-MB and CK-BB. Am J Clin Pathol. 1981;75:711–715
  60. Tsung JS, Tsung SS. Creatine kinase isoenzymes in extracts of various human skeletal muscles. Clin Chem. 1986;32:1568–1570
  61. McLaurin MD, Apple FS, Falahati A, et al. A comparison of cardiac troponin I and CK-MB to rule out myocardial injury in hospitalized patients with renal insufficiency. Circulation. 1996;94(Suppl. 1):4271
  62. Adams JE, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation. 1993;88:101–106
  63. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113:1333–1344
  64. Hamm CW, Katus HA. New biochemical markers for myocardial cell injury. Curr Opin Cardiol. 1995;10:355–360
  65. Jaffe AS. In search of specificity: the troponins. ACC Curr J Rev. 1995;5:29–33
  66. Adams JE, Schechtman KB, Landt Y, et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem. 1994;40:1291–1295
  67. Bodor GS, Porterfield D, Voss EM, et al. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41:1710–1715
  68. Haider KH, Stimson WH. Cardiac troponin I: a biochemical marker for cardiac cell necrosis. Dis Markers. 1993;11:205–215
  69. Hiramatsu T, Zund G, Schermerhorn ML, et al. Age differences in effects of hypothermic ischemia on endothelial and ventricular function. Ann Thorac Surg. 1995;60:S501–S504
  70. Grant JW, Canter CE, Spray TL, et al. Elevated donor cardiac troponin I: a marker of acute graft failure in infant heart recipients. Circulation. 1994;90:2618–2621
  71. Taggart DP, Hadjinikolas L, Wong K, et al. Vulnerability of paediatric myocardium to cardiac surgery. Heart. 1996;76:214–217

☆ This work was supported in part (financial and material) by grants CA68484, CA34183, CA79060, CA06516, HL69800, HL53392, HL59837, HL53392, and HL48012 from the National Institutes of Health, Bethesda, Md; the David B. Perini, Jr Quality of Life Program; The Laura Coulter Jones Foundation; the Parker Family Foundation; the Children's Cardiomyopathy Foundation, Dade Behring Corporation, Newark, Del; and Roche Diagnostics Corporation, Indianapolis, Ind. No funding organization played a role in the design, conduct, interpretation, or analysis of this study.

PII: S0002-8703(05)00644-7

doi: 10.1016/j.ahj.2005.06.029

American Heart Journal
Volume 151, Issue 4 , Pages 916-922 , April 2006

Article Tools